125030-71-9
|
|
- CAS号:
- 125030-71-9
- 英文名:
- Ro 24-4736
- 英文别名:
- Ro 24-4736;Ro 24 4736,Ro244736;6(5H)-Phenanthridinone, 5-[3-[4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-yl]-2-propyn-1-yl]-;4-(2-Chlorophenyl)-9-methyl-2-[3-[(5,6-dihydro-6-oxophenanthridin)-5-yl]-1-propynyl]-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
- 中文名:
- 125030-71-9
- 中文别名:
- 化合物 T16768
- CBNumber:
- CB91355010
- 分子式:
- C31H20ClN5OS
- 分子量:
- 546.04
- MOL File:
- 125030-71-9.mol
|
|
|
125030-71-9化学性质
-
熔点:
-
247-249 °C
-
|
-
沸点:
-
819.6±75.0 °C(Predicted)
-
|
-
密度:
-
1.41±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
Soluble in DMSO
-
|
-
酸度系数(pKa):
-
2.10±0.40(Predicted)
-
|
125030-71-9性质、用途与生产工艺
Ro 24-4736 是一种长效的选择性血小板活化因子 (PAF) 拮抗剂。
Ro 24-4736 competes with [
3
H]PAF for its receptor site on dog platelets with an IC
50
of 9.8±1.0 nM and selectively inhibits PAF-induced aggregation of guinea pig, dog and human platelets with concentration dependence.
Ro 24-4736 dose-dependently inhibits in vivo bronchoconstriction (ID50 of 0.006-mg/kg p.o.) and ex vivo platelet aggregation (ID
50
of 0.004 mg/kg p.o.) induced by PAF in guinea pigs. Time course studies show complete blockade of PAF-induced platelet aggregation (ex vivo) up to 8 hr after a single p.o. dose of 0.03 mg/kg as well as a long duration of action in vivo (30 hr). The in vivo PAF antagonistic activity is specific because, even at high p.o. doses (up to 10 mg/kg), Ro 24-4736 shows no inhibitory activity toward the bronchoconstrictor effects of leukotriene D4 or histamine. In comparison with other PAF antagonists evaluated in this guinea pig model, Ro 24-4736 is markedly superior in terms of p.o. potency, bioavailability and p.o. duration of action. Studies are also performed with Ro 24-4736 in additional in vivo models. When administered p.o. to sensitized guinea pigs, the drug attenuates inhaled antigen-induced airway hyper-reactivity without effect on bronchoalveolar lavage leukocyte accumulation. Ro 24-4736 is a new platelet activating factor antagonist. The tissue distribution of the
14
C-label in male rats following a single intravenous dose of 1.0 mg/kg of 14C-Ro 24-4736 indicats appreciable uptake by the liver, kidney, heart and gastrointestinal tract. Peak plasma and tissue concentrations are seen at 5 minutes after dosing except for the small intestine (4 hrs) and abdominal fat, stomach and large intestine (4 hrs). At 48 hours, only 3.5% of the dose is present in the tissues, and 6.1% in the lumen of the gastrointestinal tracts.
125030-71-9
上下游产品信息
上游原料
下游产品
125030-71-9, 125030-71-9 相关搜索:
- 化合物 T16768
- 125030-71-9
- Ro 24 4736,Ro244736
- 6(5H)-Phenanthridinone, 5-[3-[4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-yl]-2-propyn-1-yl]-
- 4-(2-Chlorophenyl)-9-methyl-2-[3-[(5,6-dihydro-6-oxophenanthridin)-5-yl]-1-propynyl]-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
- Ro 24-4736